Medical Lead - Chronic Lymphocytic Leukemia (CLL)

Role: Medical Lead for Chronic Lymphocytic Leukemia (CLL) at AstraZeneca's Oncology Business Unit, responsible for shaping and executing the US Medical Affairs strategy for this hematology-oncology indication. Responsibilities include leading the Core Medical Team, developing integrated medical plans based on scientific insights, managing investigator-initiated studies, guiding evidence generation through real-world data strategies and publication planning, and providing medical review of key materials. The role involves cross-functional collaboration with Medical, Clinical Development, Safety, Commercial, and Market Access teams, along with engagement with external scientific partners. Requirements: MD, DO, PhD, or PharmD with at least 5+ years of industry, clinical, or research experience, including 1-3 years in HQ Medical Affairs; deep expertise in Hematology/Oncology and drug development; proven leadership, strategic influence, and financial acumen. Travel up to 30% nationally and internationally is expected. Preferred qualifications include additional advanced degrees, experience with US market and regulatory requirements, clinical management of leukemia, evidence generation, and team leadership skills. High-value specifics: focus on hematology-oncology, CLL, real-world evidence, investigator-initiated studies, scientific communication, and cross-functional stakeholder engagement. Work setup: hybrid onsite in Gaithersburg, MD, with travel.